Massmutual Trust Co. FSB ADV Increases Position in CME Group Inc. (NASDAQ:CME)

Massmutual Trust Co. FSB ADV lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 62.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,216 shares of the financial services provider’s stock after acquiring an additional 6,616 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in CME Group were worth $3,799,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Salomon & Ludwin LLC bought a new position in shares of CME Group during the first quarter valued at approximately $28,000. Y.D. More Investments Ltd acquired a new stake in CME Group in the second quarter worth approximately $36,000. Rise Advisors LLC acquired a new stake in CME Group in the first quarter worth approximately $41,000. McClarren Financial Advisors Inc. lifted its position in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the period. Finally, Asset Dedication LLC lifted its position in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the period. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.3 %

Shares of CME stock opened at $224.27 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $226.78. The firm has a market cap of $80.75 billion, a PE ratio of 25.51, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The stock has a 50 day moving average of $211.69 and a 200-day moving average of $207.71. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.30 earnings per share. On average, equities analysts predict that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.05%. CME Group’s payout ratio is 52.33%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday, July 25th. Citigroup boosted their target price on shares of CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday. Finally, JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $213.77.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.